Search
for
Sort by
Research 121–150 of 1000+
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A novel therapeutic paradigm for patients with extensive alopecia areata
- New drugs under investigation for the treatment of alopecias
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Alopecia Areata
- Relapse of alopecia areata during ongoing Janus kinase inhibitor therapy is not uncommon and usually occurs in previously affected areas: A multicenter Italian real-world study
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Most Baricitinib Responders Achieved Full Scalp Hair Regrowth: Findings from Adult and Paediatric BRAVE-AA Trials
- Worldwide Clinical and Real-World Exposure to Baricitinib
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Ruxolitinib for the treatment of severe alopecia areata
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Pharmacological Treatment of Alopecia